Gregory L. Verdine

New Capabilities

Harvard chemistry professor and company co-founder

The biggest knock against blockbuster weight-loss drugs like semaglutide is that up to 40% of weight lost is lean tissue (muscle and bone), not fat. New therapies entering trials target genes to spare muscle.

Updated May 30